Follow
Helena Ostolaza
Helena Ostolaza
Professor Biochemistry
Verified email at ehu.eus
Title
Cited by
Cited by
Year
Pathophysiology of type 2 diabetes mellitus
U Galicia-Garcia, A Benito-Vicente, S Jebari, A Larrea-Sebal, H Siddiqi, ...
International journal of molecular sciences 21 (17), 6275, 2020
20442020
Surfactant-induced cell toxicity and cell lysis: A study using B16 melanoma cells
MA Partearroyo, H Ostolaza, FM Goñi, E Barberá-Guillem
Biochemical pharmacology 40 (6), 1323-1328, 1990
1581990
Familial hypercholesterolemia: the most frequent cholesterol metabolism disorder caused disease
A Benito-Vicente, KB Uribe, S Jebari, U Galicia-Garcia, H Ostolaza, ...
International journal of molecular sciences 19 (11), 3426, 2018
1422018
Release of lipid vesicle contents by the bacterial protein toxin α-haemolysin
H Ostolaza, B Bartolomé, IO de Zárate, F de la Cruz, FM Goñi
Biochimica et Biophysica Acta (BBA)-Biomembranes 1147 (1), 81-88, 1993
1361993
Glycophorin as a Receptor for Escherichia coliα-Hemolysin in Erythrocytes
AL Cortajarena, FM Goñi, H Ostolaza
Journal of Biological Chemistry 276 (16), 12513-12519, 2001
1082001
Statin treatment-induced development of type 2 diabetes: from clinical evidence to mechanistic insights
U Galicia-Garcia, S Jebari, A Larrea-Sebal, KB Uribe, H Siddiqi, ...
International journal of molecular sciences 21 (13), 4725, 2020
1032020
Membrane Restructuring by Bordetella pertussis Adenylate Cyclase Toxin, a Member of the RTX Toxin Family
C Martín, MA Requero, J Masin, I Konopasek, FM Goni, P Sebo, ...
Journal of bacteriology 186 (12), 3760-3765, 2004
1022004
Reversible adsorption and nonreversible insertion of Escherichia coli alpha-hemolysin into lipid bilayers
L Bakás, H Ostolaza, WL Vaz, FM Goñi
Biophysical journal 71 (4), 1869-1876, 1996
1021996
The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes
A Cenarro, A Etxebarria, I de Castro-Orós, M Stef, AM Bea, L Palacios, ...
The Journal of Clinical Endocrinology & Metabolism 101 (5), 2113-2121, 2016
952016
Insertion of Escherichia coliα‐haemolysin in lipid bilayers as a non‐transmembrane integral protein: prediction and experiment
A Soloaga, MP Veiga, LM García‐Segura, H Ostolaza, R Brasseur, ...
Molecular microbiology 31 (4), 1013-1024, 1999
901999
The Binding of Divalent Cations to Escherichia coliα‐Haemolysin
H Ostolaza, A Soloaga, FM Goñi
European journal of biochemistry 228 (1), 39-44, 1995
841995
Permeabilizing action of an antimicrobial lactoferricin‐derived peptide on bacterial and artificial membranes
O Aguilera, H Ostolaza, LM Quiros, JF Fierro
FEBS letters 462 (3), 273-277, 1999
801999
The calcium-binding C-terminal domain of Escherichia coli α-hemolysin is a major determinant in the surface-active properties of the protein
L Sánchez-Magraner, AR Viguera, M Garcia-Pacios, MP Garcillán, ...
Journal of biological chemistry 282 (16), 11827-11835, 2007
742007
Interaction of the bacterial protein toxin α-haemolysin with model membranes: Protein binding does not always lead to lytic activity
H Ostolaza
FEBS letters 371 (3), 303-306, 1995
721995
Calcium-dependent conformation of E. coli α-haemolysin. Implications for the mechanism of membrane insertion and lysis
L Bakás, MP Veiga, A Soloaga, H Ostolaza, FM Goñi
Biochimica et Biophysica Acta (BBA)-Biomembranes 1368 (2), 225-234, 1998
711998
A receptor-binding region in Escherichia coli α-haemolysin
AL Cortajarena, FM Goni, H Ostolaza
Journal of Biological Chemistry 278 (21), 19159-19163, 2003
702003
α-Haemolysin from E. coli purification and self-aggregation properties
H Ostolaza, B Bartolomé, JL Serra, F de la Cruz, FM Goñi
FEBS letters 280 (2), 195-198, 1991
651991
Validation of LDLr activity as a tool to improve genetic diagnosis of familial hypercholesterolemia: a retrospective on functional characterization of LDLr variants
A Benito-Vicente, KB Uribe, S Jebari, U Galicia-Garcia, H Ostolaza, ...
International journal of molecular sciences 19 (6), 1676, 2018
602018
Functional Characterization and Classification of Frequent Low‐Density Lipoprotein Receptor Variants
A Etxebarria, A Benito‐Vicente, L Palacios, M Stef, A Cenarro, F Civeira, ...
Human Mutation 36 (1), 129-141, 2015
562015
Functional characterization of splicing and ligand‐binding domain variants in the LDL receptor
A Etxebarria, L Palacios, M Stef, D Tejedor, KB Uribe, A Oleaga, ...
Human mutation 33 (1), 232-243, 2012
522012
The system can't perform the operation now. Try again later.
Articles 1–20